AbbVie Inc. (ETR:4AB)
Germany
· Delayed Price · Currency is EUR 159.20
-2.40 (-1.49%)
May 15, 2025, 5:35 PM CET
AbbVie Revenue
AbbVie had revenue of $13.34B USD in the quarter ending March 31, 2025, with 8.39% growth. This brings the company's revenue in the last twelve months to $57.37B, up 5.45% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$57.37B
Revenue Growth
+5.45%
P/S Ratio
5.27
Revenue / Employee
$1.04M
Employees
55,000
Market Cap
279.80B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 23.14B |
| Merck KGaA | 21.16B |
| Fresenius SE & Co. KGaA | 22.13B |
| Bayer Aktiengesellschaft | 46.61B |
| Fresenius Medical Care AG | 19.49B |
| Sartorius Aktiengesellschaft | 3.44B |
| Carl Zeiss Meditec AG | 2.08B |
| Fielmann Group AG | 2.33B |
AbbVie News
- 6 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit - ABBV - PRNewsWire
- 11 hours ago - Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets - Benzinga
- 20 hours ago - Dividend Checkup Amid Trump Drug Pricing Order: I Prefer AbbVie Over Pfizer - Seeking Alpha
- 21 hours ago - AbbVie Inc. (ABBV) Presents at BofA Securities 2025 Healthcare Conference (Transcript) - Seeking Alpha
- 21 hours ago - Three Stock Lunch: Advanced Micro Devices, Abbvie and Tesla - CNBC
- 22 hours ago - AbbVie wins approval of Emrelis for non-small cell lung cancer - Seeking Alpha
- 23 hours ago - Lost Money on Cerevel Therapeutics Holdings, Inc. (ABBV)? Contact Levi & Korsinsky Before June 3, 2025 to Join Class Action - Accesswire
- 23 hours ago - US FDA approves AbbVie's drug for a type of lung cancer - Reuters